Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Ganglioneuroblastoma
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug, Biological
Participants:
40
Start Date:
November 30, 2020
A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma
Clinical Trial
Status:
Recruiting
Phase:
Early Phase 1
Intervention Type:
Drug, Procedure
Participants:
20
Start Date:
September 23, 2019
Utility of Gallium-68-DOTA-Octreotate PET/CT in the Characterization of Pediatric Neuroendocrine Tumors
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug, Biological
Participants:
95
Start Date:
May 28, 2019
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Clinical Trial
Status:
Active, not recruiting
Phase:
Phase 3
Intervention Type:
Drug, Biological, Procedure, Radiation
Participants:
813
Start Date:
May 9, 2018
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug, Biological
Participants:
108
Start Date:
March 5, 2018
Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
40
Start Date:
November 25, 2014
A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Autologous T-cells Lentivirally Transduced to Express CD171-specific Chimeric Antigen Receptors
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug, Other
Participants:
621
Start Date:
July 28, 2014
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Radiation
Participants:
30
Start Date:
June 2014
Phase II Study of Proton Radiation Therapy for Neuroblastoma
Clinical Trial
Status:
Recruiting
Participants:
600
Start Date:
June 24, 2013
International Congenital Central Hypoventilation Syndrome (CCHS) REDCap Registry
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
685
Start Date:
December 2011
European Low and Intermediate Risk Neuroblastoma Protocol
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
10000
Start Date:
November 6, 2000
Neuroblastoma Biology Studies
Showing 1-11 of 11